{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:40:10Z","timestamp":1784025610848,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejso.2025.109699","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:05:52Z","timestamp":1739491552000},"page":"109699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres"],"prefix":"10.1016","volume":"51","author":[{"given":"K.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6684-0101","authenticated-orcid":false,"given":"E.","family":"Banken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"van Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.K.","family":"Voogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rothbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9513-7126","authenticated-orcid":false,"given":"I.E.G.","family":"van Hellemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-1996","authenticated-orcid":false,"given":"G.J.M.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.109699_bib1","unstructured":"Federation of Medical Specialists. Dutch National Guidelines Colorectal Cancer 2020. https:\/\/richtlijnendatabase.nl\/richtlijn\/colorectaal_carcinoom_crc\/startpagina_-_crc.html (accessed April 1, 2022)."},{"key":"10.1016\/j.ejso.2025.109699_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102177","article-title":"Total neoadjuvant therapy for rectal cancer: making sense of the results from the RAPIDO and PRODIGE 23 trials","volume":"96","author":"Giunta","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejso.2025.109699_bib3","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib7","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/annonc\/mds010","article-title":"Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?","volume":"23","author":"Glynne-Jones","year":"2012","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30097","article-title":"Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis","volume":"3","author":"Kasi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2025.109699_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10350-004-6545-x","article-title":"A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision","volume":"46","author":"Garc\u00eda-Aguilar","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2025.109699_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104196","article-title":"Total neoadjuvant therapy in rectal cancer: the evidence and expectations","volume":"192","author":"Boublikova","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2025.109699_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib13","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1245\/s10434-021-09837-8","article-title":"Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and metaanalysis of oncological and operative outcomes","volume":"28","author":"Kong","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib14","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA3504","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial","volume":"41","author":"Conroy","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1245\/s10434-021-10434-y","article-title":"Reply to: does total neoadjuvant treatment improve overall survival in rectal cancer? No, it does not","volume":"28","author":"Kong","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1245\/s10434-021-10432-0","article-title":"Does total neoadjuvant treatment improve overall survival in rectal cancer? No, it does not","volume":"28","author":"Socha","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared to long-course chemoradiotherapy and surgery - a five-year follow-up of the RAPIDO trial","author":"Dijkstra","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.109699_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/curroncol31010024","article-title":"Adoption of total neoadjuvant therapy in the treatment of locally advanced rectal cancer","volume":"31","author":"Conces","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103927","article-title":"A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer","volume":"183","author":"Simillis","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2025.109699_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2022.05.002","article-title":"Should the RAPIDO schedule represent standard of care in locally advanced rectal cancer?","volume":"33","author":"Glynne-Jones","year":"2022","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1186\/s12885-022-09947-w","article-title":"Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (\u201cugly\u201d) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)","volume":"22","author":"van den Berg","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2025.109699_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11864-016-0403-7","article-title":"Optimal imaging strategies for rectal cancer staging and ongoing management","volume":"17","author":"Balyasnikova","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib25","article-title":"MRI for rectal cancer: staging, mrCRM, EMVI, lymph node staging and post-treatment response","author":"Bates","year":"2021","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejso.2025.109699_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bjs.5917","article-title":"Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer","volume":"95","author":"Smith","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.109699_bib27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2016.68.9091","article-title":"Tumor deposits in colorectal cancer: improving the value of modern staging-A systematic review and meta-analysis","volume":"35","author":"Nagtegaal","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.2172","article-title":"Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy","volume":"154","author":"Ogura","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.109699_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ijrobp.2021.06.013","article-title":"Prognostic implications of MRI-detected EMVI and tumor deposits and their response to neoadjuvant therapy in cT3 and cT4 rectal cancer","volume":"111","author":"Schaap","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2025.109699_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2021.05.136","article-title":"Prognostic importance of MRI-detected extramural venous invasion in rectal cancer: a literature review and systematic meta-analysis","volume":"111","author":"Tan","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2025.109699_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bjs.4034","article-title":"Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging","volume":"90","author":"Brown","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.109699_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.08.020","article-title":"The significance of tumour deposits in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis","volume":"122","author":"Lord","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2025.109699_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","article-title":"Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit","volume":"26","author":"Nagtegaal","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2025.109699_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1200\/JCO.18.00032","article-title":"Neoadjuvant (Chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3\/4 rectal cancer","volume":"37","author":"Ogura","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib35","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ejso.2021.05.017","article-title":"Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: a matched case-control study","volume":"47","author":"Voogt","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib36","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.109699_bib37","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.109699_bib38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib39","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(09)70381-X","article-title":"Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial","volume":"11","author":"Chua","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13062-022-00329-7","article-title":"Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview","volume":"17","author":"Guida","year":"2022","journal-title":"Biol Direct"},{"key":"10.1016\/j.ejso.2025.109699_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eclinm.2019.09.009","article-title":"Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer","volume":"16","author":"Zhu","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejso.2025.109699_bib43","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.7314\/APJCP.2015.16.7.2993","article-title":"Can induction chemotherapy before concurrent chemoradiation impact circumferential resection margin positivity and survival in low rectal cancers?","volume":"16","author":"Bhatti","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.ejso.2025.109699_bib44","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/annonc\/mdz186","article-title":"Long-course preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study","volume":"30","author":"Cise\u0142","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2025.109699_bib45","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1200\/JCO.2021.39.15_suppl.3510","article-title":"A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): the final reports","volume":"39","author":"Jing","year":"2021","journal-title":"J Clin"},{"key":"10.1016\/j.ejso.2025.109699_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.clon.2021.06.006","article-title":"Intensified total neoadjuvant therapy in patients with locally advanced rectal cancer: a phase II trial","volume":"33","author":"De Felice","year":"2021","journal-title":"Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:51:53Z","timestamp":1746805913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0748798325001271"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109699","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109699"}}